QInscribe

QInscribe We are a specialist AI Medical Writing Contract Organisation that provides regulatory documents.

📋 Why SOPs are critical in clinical trialsStandard Operating Procedures (SOPs) provide the structure needed to ensure co...
21/04/2026

📋 Why SOPs are critical in clinical trials

Standard Operating Procedures (SOPs) provide the structure needed to ensure consistency, compliance, and quality across every stage of a clinical trial.

This blog explores:
🔹 What SOPs are and why they matter
🔹 Key components of effective SOPs
🔹 How they support regulatory compliance and operational efficiency

📖 Read the full blog:
https://hubs.li/Q04blbJk0

🔒 Clear consent builds trust and protects your clinical trial.We develop informed consent documents that are accurate, a...
17/04/2026

🔒 Clear consent builds trust and protects your clinical trial.

We develop informed consent documents that are accurate, accessible, and aligned with global ethical and regulatory expectations. We support you so you can support participants with compassionate and patient-centric communication.

👆 Learn how we support compliant, patient-focused ICD development: https://hubs.li/Q049Pddv0

🤔 What does AI mean for the future of medical writing?From speeding up document creation to supporting compliance and co...
14/04/2026

🤔 What does AI mean for the future of medical writing?

From speeding up document creation to supporting compliance and consistency, AI is transforming how clinical and regulatory teams work. How do we strike the right balance of human-in-the-loop and AI advancements?

👆 Explore the evolving role of AI in medical writing in our blog: https://hubs.li/Q049P8hl0

🏗️ Strong Standard Operating Procedures (SOPs) form the backbone of your quality and efficiency in clinical trials.If yo...
08/04/2026

🏗️ Strong Standard Operating Procedures (SOPs) form the backbone of your quality and efficiency in clinical trials.

If you need to develop clear, compliant SOPs tailored to your workflows, we can help. Reduce risk, support training, and stay inspection-ready with clear and well written SOPs.

From creation to implementation, we’ve got your process covered.

👷 Build SOPs that are tailored to your internal processes and work for your business: https://hubs.li/Q049P0fq0

🧩 Connect your research with the right audience.We help transform complex clinical results into clear, engaging scientif...
03/04/2026

🧩 Connect your research with the right audience.

We help transform complex clinical results into clear, engaging scientific communications designed to resonate with regulators, healthcare professionals (HCPs), and global audiences.

🔬 Maximise the value of your research - connect with a member of our team:

https://hubs.li/Q048zMwZ0

One Template Does Not Fit All RegulatorsA global protocol template sounds efficient, until you submit. Different regulat...
01/04/2026

One Template Does Not Fit All Regulators

A global protocol template sounds efficient, until you submit. Different regulators focus on different risks, levels of detail, and supporting evidence. The European Medicines Agency (EMA) operates within the Clinical Trials Regulation (CTR) and the Clinical Trials Information System (CTIS) model, while the Food and Drug Administration (FDA) follows the Investigational New Drug (IND) process. The International Council for Harmonisation (ICH) sets a foundation, not a universal template.

QInscribe helps teams write submission ready documents that match each authority’s expectations and stand up to review.

Planning a multi region submission? See how we can help: https://hubs.li/Q048B2pz0

Patient-centric communication means writing so people can actually understand and use the information. In pharma marketi...
26/03/2026

Patient-centric communication means writing so people can actually understand and use the information. In pharma marketing, that builds trust and reduces confusion. The key is adjusting the same science for different readers, patients need plain language and relevance, healthcare professionals need clear evidence, and payers need outcomes and value. One message, tailored thoughtfully.

See how we can help 👇

Enquire now: https://hubs.li/Q046SPqg0
📩 info@qinscribe.com

Medical writing isn’t just “documents” anymore, it’s becoming a strategic capability at the intersection of regulation, ...
23/03/2026

Medical writing isn’t just “documents” anymore, it’s becoming a strategic capability at the intersection of regulation, data, and patient trust.

📈 Market momentum: The global medical writing market is projected to grow from ~$4.23B (2025) to ~$4.67B (2026) (~10.3% YoY CAGR).

• Patient-centric communication is now expected
Plain-language content is expanding fast, especially with EU expectations around layperson-friendly trial information.

• Rise of Real-World Evidence (RWE)
RWE is increasingly influencing submissions and scientific narratives, pushing stronger integration of RWD/RWE insights into regulatory documents.

• GCP modernization (ICH E6(R3))
With ICH E6(R3) adopted on 06 Jan 2025, teams are strengthening traceability, quality-by-design language, and oversight documentation across clinical deliverables.

• Structured content & digital-ready protocols (ICH M11)
Movement toward structured protocol templates and technical specs is driving modular content, reuse, and consistency across studies.

• AI-augmented workflows (with governance)
AI can speed up drafting and QC, but the differentiator is compliant processes, review discipline, and audit-ready outputs.

If you’re scaling submissions, tightening timelines, or aligning to evolving guidance, QInscribe can support end-to-end regulatory and clinical writing, from protocols and CSRs to CTD summaries, transparency deliverables, and standalone QC.

Enquire now: https://hubs.li/Q046SWQZ0
📩 info@qinscribe.com

Clinical trial transparency isn’t just “nice to have." It is foundational to ethical, reliable healthcare decisions.Here...
19/03/2026

Clinical trial transparency isn’t just “nice to have." It is foundational to ethical, reliable healthcare decisions.

Here is why clinical trial transparency is important:

• Ethical responsibility to participants
Honours participant risk and contribution by ensuring results are shared openly.

• Minimises bias and strengthens scientific accuracy
Reduces publication/selection bias by making negative and neutral findings visible too.

• Protects patients through safer clinical decisions
Enables clinicians and authorities to judge true safety/efficacy and avoid harmful use.

• Builds trust and credibility in research
Improves confidence among the public, researchers, and healthcare professionals.

• Enables better regulatory and policy decisions
Supports evidence-based approvals and guidance by ensuring decision-makers have the full data picture.

See how our team can support accurate, on-time disclosures for you: https://hubs.li/Q046SPBm0

A strong Plain Language Summary (PLS) isn’t structured around internal report sections, it’s built around what readers t...
16/03/2026

A strong Plain Language Summary (PLS) isn’t structured around internal report sections, it’s built around what readers truly need to know.

Use this strategic PLS checklist when developing your next summary:

✅ Purpose: Why was the study conducted?
✅ Who, where & why: Who participated, where the study took place, and why it mattered
✅ What happened: Treatments/interventions explained in simple terms
✅ Results: Key findings presented, clearly and without jargon (no extra stats)
✅ Harms & side effects: Safety insights shared honestly and neutrally
✅ Next steps: What the result may mean for future research or patient care

Clear. Patient focused. Impactful.
Exactly how a PLS should be.

Medical Writing Consultancy turns regulatory complexity into clear next steps 👇✅ Regulatory strategy: Define the right p...
09/03/2026

Medical Writing Consultancy turns regulatory complexity into clear next steps 👇

✅ Regulatory strategy: Define the right pathway, anticipate expectations, and move toward smoother, faster approvals.
✅ Risk mitigation: Spot compliance gaps early to avoid delays and costly rework.
✅ Operational efficiency: Streamline documentation with tailored, practical solutions.
✅ Submission readiness: Be confident for regulatory interactions, audits, and submissions.

What is CTIS? CTIS (Clinical Trials Information System) is the EU’s single portal and public database for clinical trial...
04/03/2026

What is CTIS?

CTIS (Clinical Trials Information System) is the EU’s single portal and public database for clinical trials under EU-CTR 536/2014.

It’s where sponsors:

✅ submit and manage trial applications across EU/EEA
✅ upload key trial documents and updates
✅ disclose results, including Plain Language Summaries for public access

Why it matters: CTIS makes transparency the default, so your disclosures need to be clear, consistent, and submission-ready.

Need help with CTIS results disclosure or trial registrations? Contact our team and learn more about our services: https://hubs.li/Q045v-mR0

Address

Bevan House, 9-11 Bancroft Court
Hitchin
SG51LH

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+441462440084

Website

https://www.linkedin.com/company/qinscribe/

Alerts

Be the first to know and let us send you an email when QInscribe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to QInscribe:

Share